S.C. Oncologia - Fondazione IRCCS Policlinico S. Matteo
Welcome,         Profile    Billing    Logout  
 5 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pedrazzoli, Paolo
AtezoMeso, NCT04996017 / 2020-003762-39: Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)

Recruiting
3
162
Europe
Atezolizumab 1200 mg in 20 ML Injection, Placebo
Gruppo Oncologico Italiano di Ricerca Clinica, Roche S.p.A.
Mesotheliomas Pleural
12/23
12/23
NCT02375204: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Active, not recruiting
3
420
Europe, US, RoW
paclitaxel, Taxol, ifosfamide, Ifex®, IFOS, cisplatin, CDDP, pegylated G-CSF, G-CSF, carboplatin, Paraplatin®, CBDCA, etoposide phosphate, VePesid®, Toposar®, VP16, stem cell reinfusion
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), European Organisation for Research and Treatment of Cancer - EORTC, Movember Foundation, Institute of Cancer Research (ICR), United Kingdom, Cancer Research UK, UNICANCER, Irish Group CTI
Germ Cell Tumor, Teratoma, Choriocarcinoma, Germinoma, Mixed Germ Cell Tumor, Yolk Sac Tumor, Childhood Teratoma, Malignant Germ Cell Neoplasm, Extragonadal Seminoma, Non-seminomatous Germ Cell Tumor, Seminoma
06/24
06/24
ICONIC, NCT05229614: Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease

Recruiting
2
27
Europe
Carbon Ion Therapy, Immunotherapy (Pembrolizumab), Pembrolizumab
CNAO National Center of Oncological Hadrontherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma, Urothelial Carcinoma
08/25
08/26
IRMO, NCT06337019: The Italian Registry of Malnutrition in Oncology

Recruiting
N/A
1500
Europe
Cohort observational
Fondazione IRCCS Policlinico San Matteo di Pavia, Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Cancer, Cancer Metastatic
10/27
10/27
NCT04611113: Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer

Recruiting
N/A
86
Europe
Immunonutrition, Control Nutritional Support
IRCCS Policlinico S. Matteo
Head and Neck Cancer
11/22
11/22
IVANS, NCT03949907: Early IntraVenous Administration of Nutritional Support

Recruiting
N/A
192
Europe
Nutritional counseling alone, Early supplemental parenteral nutrition plus nutritional counseling
IRCCS Policlinico S. Matteo
Cancer of Stomach, GastroEsophageal Cancer
10/23
10/23
NCT05968677: Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients

Recruiting
N/A
60
Europe
FSMP, Nutritional counseling
Flavolife Srl
Breast Cancer
08/24
08/25
METAMECH, NCT04625023: A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer

Recruiting
N/A
500
Europe
Observational
IFOM ETS - The AIRC Institute of Molecular Oncology
Breast Cancer
07/26
12/26
RATIONAL, NCT05918666: National Register of Actionable Mutations

Recruiting
N/A
3000
Europe
Federation of Italian Cooperative Oncology Groups, Roche Pharma AG, AstraZeneca, Bayer, Bristol-Myers Squibb, Janssen, LP, Takeda, Amgen, Daiichi Sankyo, Inc., Eli Lilly and Company, Novartis, Clinical Research Technology S.r.l.
Solid Tumours in Advanced Stages
10/26
10/26

Download Options